Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight
We present a review and analysis of the ethical considerations in off-label ketamine use for severe, treatment-resistant depression. The analysis of ethical considerations is contextualised in an overview of the evidence for ketamine use in depression, and a review of the drug's safety profile....
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2017
|